Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (501-510 of 522) with videos related to

Pageof 53
Sort By:
The American Journal of Surgical Pathology|September 17, 2016
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective CohortJesse K McKenney, Wei Wei, Sarah Hawley, et al.
Prostate Cancer and Prostatic Diseases|March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registryOliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
The Journal of Urology|August 26, 2021
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 ConsortiumPeter Chang, Andrew A Wagner, Meredith M Regan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinomaEmily Chan, Jesse K McKenney, Sarah Hawley, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancerUdit Singhal, Ralph Jiang, James A Proudfoot, et al.
JAMA Oncology|May 12, 2017
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation TherapyShuang G Zhao, S Laura Chang, Nicholas Erho, et al.
JAMA Network Open|October 24, 2024
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of LifeSagar A Patel, Dattatraya Patil, Joseph Smith, et al.
JCO Precision Oncology|January 20, 2022
Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the ProstateWilliam A Hall, Nick Fishbane, Yang Liu, et al.
The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
Pageof 53

Showing results (501-510 of 522) with videos related to

Sort By:
Pageof 53
The American Journal of Surgical Pathology|September 17, 2016
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective CohortJesse K McKenney, Wei Wei, Sarah Hawley, et al.
Prostate Cancer and Prostatic Diseases|March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registryOliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
The Journal of Urology|August 26, 2021
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 ConsortiumPeter Chang, Andrew A Wagner, Meredith M Regan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinomaEmily Chan, Jesse K McKenney, Sarah Hawley, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancerUdit Singhal, Ralph Jiang, James A Proudfoot, et al.
JAMA Oncology|May 12, 2017
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation TherapyShuang G Zhao, S Laura Chang, Nicholas Erho, et al.
JAMA Network Open|October 24, 2024
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of LifeSagar A Patel, Dattatraya Patil, Joseph Smith, et al.
JCO Precision Oncology|January 20, 2022
Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the ProstateWilliam A Hall, Nick Fishbane, Yang Liu, et al.
The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
Pageof 53